# A Comparison of NETSPOT Imaging Versus F-FDG-PET in Head and Neck Cancer Patients

> **NCT03602911** · PHASE2 · COMPLETED · sponsor: **West Virginia University** · enrollment: 20 (actual)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma

## Interventions

- **DRUG:** The isotope 68Ga, NETSPOT and 18F-FDG-PET/CT

## Key facts

- **NCT ID:** NCT03602911
- **Lead sponsor:** West Virginia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-01
- **Primary completion:** 2021-04-01
- **Final completion:** 2021-04-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03602911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03602911, "A Comparison of NETSPOT Imaging Versus F-FDG-PET in Head and Neck Cancer Patients". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03602911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*